Race Oncology Ltd Cash Flow Reinvestment Rate

Latest as of December 2024: 0.00x

Race Oncology Ltd cash flow reinvestment rate. Race Oncology Ltd (RAC) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting AU$4.00 (capex AU$4.00 ) from operating cash flow of AU$570.64K. Explore Race Oncology Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

AU$4.00
Capex + Investments

Operating Cash Flow

AU$570.64K
AUD

Capital Expenditures

AU$4.00
AUD

Cash Flow Reinvestment Rate of Race Oncology Ltd (2011–2013)

Cash flow reinvestment rate of Race Oncology Ltd from 2011 to 2013. Historical reinvestment intensity for Race Oncology Ltd across 3 annual periods. Explore Race Oncology Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Race Oncology Ltd Cash Flow Reinvestment Rate by Year (2011–2013)

Race Oncology Ltd cash flow reinvestment rate by year from 2011 to 2013. Year-by-year capital reinvestment analysis for Race Oncology Ltd. For the full cash flow conversion analysis, see Race Oncology Ltd (RAC) cash flow conversion.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2013 1.20x AU$4.44 Million AU$3.71 Million AU$31.00K ▼ -77.5%
2012 5.33x AU$35.61 Million AU$6.68 Million AU$218.00K ▲ +414.5%
2011 1.04x AU$12.34 Million AU$11.92 Million AU$72.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow